Trial intelligence / Profile preview

Omnivirol + Salicylic Acid for Cutaneous Warts

NCT05862441Phase 3Completed

Sponsor
University of Antwerp
Start
Jan 2018
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of AV2 in cutaneous warts, sponsored by University of Antwerp. Started Jan 2018; status: completed.

02

Drugs

AV2
03

Conditions

cutaneous warts

Beyond the preview

Go deeper on NCT05862441.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05862441.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call